|
|
|
40
|
0014K
|
CHLORPHENIRAMINE 10MG/ML IV/IM INJ (MON/PHA)
|
CHLORPHENIRAMINE
|
CHLORPHENIRAMINE
|
10X1ML
|
B
|
6.96
|
0.70
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
0404
|
FIRST GENERATION ANTIHISTAMINES
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
0
|
ANTIHISTAMINICS
|
|
|
|
|
42
|
0164AR
|
AMPICILLIN 500MG INJ (MON)
|
AMPICILLIN
|
AMPICILLIN
|
10X5ML
|
B
|
13.18
|
1.32
|
VIAL
|
28
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2026-04-01
|
|
|
IV
|
0
|
PENICILLINS
|
|
|
|
|
40
|
0164AW
|
AMPICILLIN 500MG INJ (MON/PHA)
|
AMPICILLIN
|
AMPICILLIN
|
500MG VIAL
|
C
|
1.69
|
1.69
|
INJECTION
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0164AW
|
AMPICILLIN 500MG INJ (MON) (BQ)
|
AMPICILLIN
|
AMPICILLIN
|
500MG VIAL
|
BQ
|
1.85
|
1.8485
|
VIAL
|
28
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PENICILLINS
|
|
|
|
|
42
|
0211AE
|
MEROPENEM 500MG INJ (MON)
|
MEROPENEM
|
MEROPENEM
|
500MG VIAL
|
BQ
|
4.92
|
4.92
|
VIAL
|
42
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120708
|
CARBAPENEMS
|
2026-04-01
|
|
|
IV
|
0
|
CARBAPENEMS
|
|
|
|
|
41
|
0211AT
|
MEROPENEM 500MG INJ (MON) (BQ)
|
MEROPENEM
|
MEROPENEM
|
10X500MG
|
BQ
|
9.49
|
0.9487
|
VIAL
|
42
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
ALI
|
ALL HEALTH INC
|
|
08120708
|
CARBAPENEMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
2
|
CARBAPENEMS
|
|
|
|
|
42
|
0212BC
|
MEROPENEM 1G INJ (MON)
|
MEROPENEM
|
MEROPENEM
|
1G VIAL
|
BQ
|
5.95
|
5.95
|
VIAL
|
42
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120708
|
CARBAPENEMS
|
2026-04-01
|
|
|
IV
|
0
|
CARBAPENEMS
|
|
|
|
|
40
|
0225K
|
CLOXACILLIN 500MG INJ (MON/PHA)
|
CLOXACILLIN
|
CLOXACILLIN
|
500MG VIAL
|
B
|
1.58
|
1.58
|
INJECTION
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
42
|
0301P
|
CLINDAMYCIN PHOSPHATE 150MG/ML INJ
|
CLINDAMYCIN PHOSPHATE
|
CLINDAMYCIN PHOSPHATE
|
5X2ML
|
BQ
|
8.02
|
1.60
|
AMPG
|
112
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
0812
|
ANTIBACTERIALS
|
2026-04-01
|
|
|
IV
|
0
|
ANTIBACTERIALS
|
|
|
|
|
40
|
0453C
|
CO-TRIMOXAZOLE 80MG/ML | 16MG/ML INJ (MON/PHA)
|
SULFAMETHOXAZOLE|TRIMETHOPRIM
|
CO-TRIMOXAZOLE
|
5X5ML
|
B
|
10.06
|
2.01
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081220
|
SULPHONAMIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
42
|
0453C
|
CO-TRIMOXAZOLE 80MG/ML|16MG/ML INJ (MON) SULFAMETHOXAZOLE|TR
|
SULFAMETHOXAZOLE|TRIMETHOPRIM
|
CO-TRIMOXAZOLE
|
5X5ML
|
B
|
8.02
|
1.60
|
AMPG
|
20
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081220
|
SULPHONAMIDES
|
2026-04-01
|
|
|
IV
|
0
|
SULPHONAMIDES
|
|
|
|
|
42
|
06928
|
NEOSTIGMINE 2.5MG/ML INJ (MON)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X1ML
|
BQ
|
13.18
|
1.32
|
AMPG
|
0
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
40
|
0692L
|
NEOSTIGMINE 2.5MG/ML INJ (MON/PHA)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
5X1ML
|
BQ
|
7.83
|
1.57
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
0694A
|
NEOSTIGMINE 2.5MG/ML INJ (MON/PHA)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
5X5ML
|
BQ
|
19.14
|
3.83
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
42
|
0694A
|
NEOSTIGMINE 2.5MG/ML INJ (MON)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
5X5ML
|
BQ
|
15.49
|
3.10
|
AMPG
|
0
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
40
|
0711AF
|
ATROPINE SULPHATE 0.5MG/ML IV/IM INJ (MON/PHA)
|
ATROPINE SULPHATE
|
ATROPINE SULPHATE
|
10X1ML
|
B
|
6.36
|
0.64
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
0711AF
|
ATROPINE SULPHATE 0.5MG/ML IV/IM INJ (MON) (B)
|
ATROPINE SULPHATE
|
ATROPINE SULPHATE
|
10X1ML
|
B
|
8.32
|
0.8318
|
AMP
|
10
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1208
|
ANTICHOLINERGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
ANTICHOLINERGIC AGENTS
|
|
|
|
|
42
|
0711AF
|
ATROPINE SULPHATE 0.5MG/ML IV/IM INJ (MON)
|
ATROPINE SULPHATE
|
ATROPINE SULPHATE
|
10X1ML
|
B
|
7.75
|
0.78
|
AMPG
|
10
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1208
|
ANTICHOLINERGIC AGENTS
|
2026-04-01
|
|
|
IV/IM
|
0
|
ANTICHOLINERGIC AGENTS
|
|
|
|
|
42
|
0742L
|
BENZTROPINE 1MG/ML INJ (MON)
|
BENZTROPINE
|
BENZTROPINE
|
5X2ML
|
B
|
13.43
|
2.69
|
AMPG
|
6
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
283608
|
ANTICHOLINERGIC AGENTS (PARKINSONS)
|
2026-04-01
|
|
|
IV
|
6
|
ANTICHOLINERGIC AGENTS (PARKINSONS)
|
|
|
|
|
40
|
0752K
|
HYOSCINE BUTYLBROMIDE 20MG/ML INJ (MON/PHA)
|
HYOSCINE BUTYLBROMIDE
|
HYOSCINE BUTYLBROMIDE
|
10X1ML
|
B
|
16.26
|
1.63
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|